The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology. 

The document, which was designed to help guide both interventional cardiology trainees and program directors, was also endorsed by several other industry societies. 

Hospital end-users ranked the CVIS and hemodynamic systems they are using and shed light on their working relationships with IT vendors. 

When long-term continuous monitoring detects bradyarrhythmia in an asymptomatic patient, is it still providing value? 

Some SGLT2 inhibitors have been linked to significant improvements in HF outcomes, but what about sotagliflozin? We spoke with Bertram Pitt, MD, to learn more.

The report, developed by Abbott, examined everything from AI to social determinants of health. One key finding was that patients grade their overall satisfaction with a physician or hospital based on much more than the effectiveness of their treatment. 

Can ChatGPT discuss preventive cardiology with patients? Cardiologists with Cleveland Clinic and Stanford University put the popular AI model to the test, sharing their findings in JAMA.

Minnesota-based Cardiovascular Systems Inc. is perhaps best known for its atherectomy devices designed to treat PAD and CAD.

Even as progress is being made, some lawmakers want to increase penalties on hospitals that do not comply. 

The closure of the deal comes after Amazon faced some backlash toward the acquisition, with some arguing the move gives the retailer too much power.